Xeraya Capital
Malaysia-based venture capital and private equity firm investing globally in life sciences, including biotech, medical technologies, biorenewables and agritech.
Xeraya Capital is a Malaysia-based venture capital and private equity firm investing globally in life sciences. Its remit spans medical technologies, pharmaceutical biotechnology, biorenewables, agritech and drug development, with a stated focus on connecting global investment opportunities to Malaysia's scientific landscape and driving value locally. Geographic presence covers Malaysia, the United States, Europe and Asia.
The firm invests across both venture capital and private equity structures, supporting companies from early platform technologies through more mature clinical stages. Sector coverage includes clinical-stage biotechnology, healthcare, pharmaceuticals and sustainability-oriented innovations. Xeraya Capital describes its objective as catalysing life sciences breakthroughs addressing unmet needs in healthcare and global sustainability.
The firm states a long-term, partnership-oriented approach with portfolio companies, with core values described as partnership, integrity and responsibility. It collaborates with global venture capital groups as part of its sourcing and investment activity.